Crossject is revolutionizing needle free injection

Paragraphes
Colonne 1

Crossject is revolutionizing the administration of well-established, clinically-proven treatments and bringing unprecedented advantages to patients with its innovative, needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has eight ZENEO® solutions in advanced stages of development, seven of which are for emergency situations.  

Zeneo illustration

 

Our news

Image de l'actualité

Crossject will be attending J.P. Morgan Healthcare conference

Résumé de l'actualité

During the 2nd week of January 2019, Crossject will be in San Francisco around the J.P. Morgan Healthcare Conference, to meet with American pharmaceutical companies.

Image de l'actualité

Patrick Alexandre: « Lorsque l’on regarde ce qui a été accompli, nous avons de réelles raisons d’être fiers. »

Résumé de l'actualité

Patrick Alexandre, PDG de Crossject, a répondu aux questions de Didier TESTOT pour LA BOURSE ET LA VIE TV.

 

Image

Financial news: Crossject - Slideshow Annual results 2018

Sommaire ou résumé

Annual results 2018